The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose

Mohd Radzniwan Rashid, Khairun Nain Nor Aripin, Fathima Begum Syed Mohideen, Nizam Baharom, Khairani Omar, Nik Mohd Shafikudin Md Taujuddin, Hazira Hanum Mohd Yusof, Faizul Helmi Addnan

Research output: Contribution to journalArticle

Abstract

Background. Impaired fasting glucose (IFG) poses a higher risk of diabetes. Honey has been reported to improve metabolic abnormalities including lowering hyperglycemia. This study is sought at determining the effect of Malaysian Kelulut honey (KH) on fasting glucose levels and metabolic parameters in IFG patients. Methods. This quasi-experimental intervention study of 30-day duration was conducted among 60 adult patients with IFG. They were allocated into taking 30 g/day KH group (experimental group, n=30) and not taking KH group (control group, n=30). Body mass index (BMI), waist circumference, blood pressure (BP), fasting glucose, and lipid profile levels (total cholesterol, triglyceride, high-density lipoprotein, and low-density lipoprotein) were measured before and after treatment. Results. There was no significant difference in all measured variables at day 30 compared to day 1 within both groups. Similarly, all measured variables neither at day 1 nor at day 30 had shown a statistically significant difference between the groups. Conclusions. Daily intake of 30 g KH for 30 days resulted in insignificant effect on fasting glucose, fasting lipid profiles, and other metabolic parameters in patients with IFG. Further studies that employ longer study duration are needed to ascertain the finding.

Original languageEnglish
Article number3176018
JournalJournal of Nutrition and Metabolism
Volume2019
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Honey
honey
blood glucose
fasting
Blood Glucose
Fasting
Glucose
glucose
Lipids
duration
Metabolome
high density lipoprotein
waist circumference
Waist Circumference
hyperglycemia
low density lipoprotein
lipids
LDL Lipoproteins
Hyperglycemia
HDL Cholesterol

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Food Science
  • Nutrition and Dietetics

Cite this

Rashid, M. R., Nor Aripin, K. N., Syed Mohideen, F. B., Baharom, N., Omar, K., Md Taujuddin, N. M. S., ... Addnan, F. H. (2019). The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose. Journal of Nutrition and Metabolism, 2019, [3176018]. https://doi.org/10.1155/2019/3176018

The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose. / Rashid, Mohd Radzniwan; Nor Aripin, Khairun Nain; Syed Mohideen, Fathima Begum; Baharom, Nizam; Omar, Khairani; Md Taujuddin, Nik Mohd Shafikudin; Mohd Yusof, Hazira Hanum; Addnan, Faizul Helmi.

In: Journal of Nutrition and Metabolism, Vol. 2019, 3176018, 01.01.2019.

Research output: Contribution to journalArticle

Rashid, MR, Nor Aripin, KN, Syed Mohideen, FB, Baharom, N, Omar, K, Md Taujuddin, NMS, Mohd Yusof, HH & Addnan, FH 2019, 'The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose', Journal of Nutrition and Metabolism, vol. 2019, 3176018. https://doi.org/10.1155/2019/3176018
Rashid, Mohd Radzniwan ; Nor Aripin, Khairun Nain ; Syed Mohideen, Fathima Begum ; Baharom, Nizam ; Omar, Khairani ; Md Taujuddin, Nik Mohd Shafikudin ; Mohd Yusof, Hazira Hanum ; Addnan, Faizul Helmi. / The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose. In: Journal of Nutrition and Metabolism. 2019 ; Vol. 2019.
@article{f362c2430b8d4b58ba36af50a31e97fa,
title = "The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose",
abstract = "Background. Impaired fasting glucose (IFG) poses a higher risk of diabetes. Honey has been reported to improve metabolic abnormalities including lowering hyperglycemia. This study is sought at determining the effect of Malaysian Kelulut honey (KH) on fasting glucose levels and metabolic parameters in IFG patients. Methods. This quasi-experimental intervention study of 30-day duration was conducted among 60 adult patients with IFG. They were allocated into taking 30 g/day KH group (experimental group, n=30) and not taking KH group (control group, n=30). Body mass index (BMI), waist circumference, blood pressure (BP), fasting glucose, and lipid profile levels (total cholesterol, triglyceride, high-density lipoprotein, and low-density lipoprotein) were measured before and after treatment. Results. There was no significant difference in all measured variables at day 30 compared to day 1 within both groups. Similarly, all measured variables neither at day 1 nor at day 30 had shown a statistically significant difference between the groups. Conclusions. Daily intake of 30 g KH for 30 days resulted in insignificant effect on fasting glucose, fasting lipid profiles, and other metabolic parameters in patients with IFG. Further studies that employ longer study duration are needed to ascertain the finding.",
author = "Rashid, {Mohd Radzniwan} and {Nor Aripin}, {Khairun Nain} and {Syed Mohideen}, {Fathima Begum} and Nizam Baharom and Khairani Omar and {Md Taujuddin}, {Nik Mohd Shafikudin} and {Mohd Yusof}, {Hazira Hanum} and Addnan, {Faizul Helmi}",
year = "2019",
month = "1",
day = "1",
doi = "10.1155/2019/3176018",
language = "English",
volume = "2019",
journal = "Journal of Nutrition and Metabolism",
issn = "2090-0724",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose

AU - Rashid, Mohd Radzniwan

AU - Nor Aripin, Khairun Nain

AU - Syed Mohideen, Fathima Begum

AU - Baharom, Nizam

AU - Omar, Khairani

AU - Md Taujuddin, Nik Mohd Shafikudin

AU - Mohd Yusof, Hazira Hanum

AU - Addnan, Faizul Helmi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background. Impaired fasting glucose (IFG) poses a higher risk of diabetes. Honey has been reported to improve metabolic abnormalities including lowering hyperglycemia. This study is sought at determining the effect of Malaysian Kelulut honey (KH) on fasting glucose levels and metabolic parameters in IFG patients. Methods. This quasi-experimental intervention study of 30-day duration was conducted among 60 adult patients with IFG. They were allocated into taking 30 g/day KH group (experimental group, n=30) and not taking KH group (control group, n=30). Body mass index (BMI), waist circumference, blood pressure (BP), fasting glucose, and lipid profile levels (total cholesterol, triglyceride, high-density lipoprotein, and low-density lipoprotein) were measured before and after treatment. Results. There was no significant difference in all measured variables at day 30 compared to day 1 within both groups. Similarly, all measured variables neither at day 1 nor at day 30 had shown a statistically significant difference between the groups. Conclusions. Daily intake of 30 g KH for 30 days resulted in insignificant effect on fasting glucose, fasting lipid profiles, and other metabolic parameters in patients with IFG. Further studies that employ longer study duration are needed to ascertain the finding.

AB - Background. Impaired fasting glucose (IFG) poses a higher risk of diabetes. Honey has been reported to improve metabolic abnormalities including lowering hyperglycemia. This study is sought at determining the effect of Malaysian Kelulut honey (KH) on fasting glucose levels and metabolic parameters in IFG patients. Methods. This quasi-experimental intervention study of 30-day duration was conducted among 60 adult patients with IFG. They were allocated into taking 30 g/day KH group (experimental group, n=30) and not taking KH group (control group, n=30). Body mass index (BMI), waist circumference, blood pressure (BP), fasting glucose, and lipid profile levels (total cholesterol, triglyceride, high-density lipoprotein, and low-density lipoprotein) were measured before and after treatment. Results. There was no significant difference in all measured variables at day 30 compared to day 1 within both groups. Similarly, all measured variables neither at day 1 nor at day 30 had shown a statistically significant difference between the groups. Conclusions. Daily intake of 30 g KH for 30 days resulted in insignificant effect on fasting glucose, fasting lipid profiles, and other metabolic parameters in patients with IFG. Further studies that employ longer study duration are needed to ascertain the finding.

UR - http://www.scopus.com/inward/record.url?scp=85062372756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062372756&partnerID=8YFLogxK

U2 - 10.1155/2019/3176018

DO - 10.1155/2019/3176018

M3 - Article

AN - SCOPUS:85062372756

VL - 2019

JO - Journal of Nutrition and Metabolism

JF - Journal of Nutrition and Metabolism

SN - 2090-0724

M1 - 3176018

ER -